Mv Capital Management, Inc. Gamida Cell Ltd. Transaction History

Mv Capital Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$1.15 - $2.1 $2,300 - $4,200	2,000 Added 28.93%	8,913 $0
Q2 2022 Jul 19, 2022	BUY	$1.73 - $4.29 $3,460 - $8,580	2,000 Added 40.71%	6,913 $12,000
Q3 2021 Nov 12, 2021	BUY	$3.85 - $6.44 $18,915 - $31,639	4,913 New	4,913 $19,000

31.4K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mv Capital Management, Inc. with notifications on news.